Cargando…
Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
INTRODUCTION: Systemic sclerosis is an autoimmune disease characterized by tissue fibrosis and microangiopathy. Vascular changes such as a decrease in capillary density diminish blood flow and impair tissue oxygenation. Reliable ways to monitor disease activity and predict disease progression are de...
Autores principales: | Maciejewska, Magdalena, Sikora, Mariusz, Stec, Albert, Zaremba, Michał, Maciejewski, Cezary, Pawlik, Katarzyna, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307739/ https://www.ncbi.nlm.nih.gov/pubmed/37316749 http://dx.doi.org/10.1007/s13555-023-00952-w |
Ejemplares similares
-
Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023) -
The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
por: Stec, Albert, et al.
Publicado: (2023) -
Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022) -
The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023) -
Future Treatment Options in Systemic Sclerosis—Potential Targets and Ongoing Clinical Trials
por: Bohdziewicz, Anna, et al.
Publicado: (2022)